At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 15 enrolled
Drug / intervention
fluticasone furoate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen
In Brief
A Phase 4 clinical trial evaluating fluticasone furoate and Placebo for Allergic Rhinitis. Completed, enrolled 15 participants across 1 site.
Detailed Summary
The purpose of this study is to help us to a better understanding of how nose and eye symptoms are related in patients with allergies.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAllergic Rhinitis
CountriesUnited States
CollaboratorsGlaxoSmithKline
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2008
First PostedNov 2008
Primary CompletionApr 2009
Study CompletionMay 2010
TodayJul 2026
First PostedNov 17, 2008
Enrollment StartNov 1, 2008
Primary CompletionApr 1, 2009
Study CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 17.6 years ago
Interventions
fluticasone furoatedrug
2 puffs in each nostril once daily for 1 week
Placebodrug
2 puffs in each nostril once daily for 1 week